Alimentary Pharmacology & Therapeutics

Cover image for Vol. 39 Issue 4

February 2014

Volume 39, Issue 4

Pages 349–445

  1. SYSTEMATIC REVIEW WITH META-ANALYSIS

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. REVIEW ARTICLES
    4. COELIAC DISEASE
    5. IRRITABLE BOWEL SYNDROME
    6. INVITED COMMENTARY
    7. LETTERS TO THE EDITORS
  2. REVIEW ARTICLES

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. REVIEW ARTICLES
    4. COELIAC DISEASE
    5. IRRITABLE BOWEL SYNDROME
    6. INVITED COMMENTARY
    7. LETTERS TO THE EDITORS
    1. You have full text access to this OnlineOpen article
  3. COELIAC DISEASE

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. REVIEW ARTICLES
    4. COELIAC DISEASE
    5. IRRITABLE BOWEL SYNDROME
    6. INVITED COMMENTARY
    7. LETTERS TO THE EDITORS
    1. Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease (pages 418–425)

      T. Ilus, K. Kaukinen, L. J. Virta, H. Huhtala, M. Mäki, K. Kurppa, M. Heikkinen, M. Heikura, E. Hirsi, K. Jantunen, V. Moilanen, C. Nielsen, M. Puhto, H. Pölkki, I. Vihriälä and P. Collin

      Article first published online: 6 JAN 2014 | DOI: 10.1111/apt.12606

  4. IRRITABLE BOWEL SYNDROME

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. REVIEW ARTICLES
    4. COELIAC DISEASE
    5. IRRITABLE BOWEL SYNDROME
    6. INVITED COMMENTARY
    7. LETTERS TO THE EDITORS
  5. INVITED COMMENTARY

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. REVIEW ARTICLES
    4. COELIAC DISEASE
    5. IRRITABLE BOWEL SYNDROME
    6. INVITED COMMENTARY
    7. LETTERS TO THE EDITORS
    1. You have free access to this content
  6. LETTERS TO THE EDITORS

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. REVIEW ARTICLES
    4. COELIAC DISEASE
    5. IRRITABLE BOWEL SYNDROME
    6. INVITED COMMENTARY
    7. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
      Letter: the feasibility and safety of accelerated infliximab infusions in patients with inflammatory bowel disease (pages 444–445)

      Ó. Nantes, C. Rodríguez, M. Basterra, M. Gómez, K. Cambra, B. Ibáñez, I. Fernandez-Urien and A. Arín

      Article first published online: 22 JAN 2014 | DOI: 10.1111/apt.12607

SEARCH

SEARCH BY CITATION